NikoleV Posted June 14, 2013 Share Posted June 14, 2013 ASCO Update: Molecular Selection of Chemo for Advanced NSCLC Fails to Deliver June 10th, 2013 - by Dr. Jack West http://expertblog.lungevity.org/2013/06 ... o-deliver/ Dr. Mary Pinder, from Moffitt Cancer Center in Tampa, FL, was one of the investigators very involved in a high profile trial called MADeIT, which directly tested whether we might do better with chemo by selecting a particular regimen for each patient based on molecular markers for the cancer. Here’s her discussion of the trial, along with another from Spain presented at ASCO 2013 that demonstrated no improvement in outcomes with this approach, and the implications of this work for treatment of advanced NSCLC today: (Click link above to view the video) Molecular Selection of Chemo for NSCLC ASCO 2013 Trials Video More to come, including some video summaries that describe more encouraging results! -Dr. West Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.